Skip to content

Comparison of Intraoperative Intravenous Lidocaine Infusion and Transversus Abdominis Plane (TAP) Block for Post-operative Analgesia Following Laproscopic Cholecystectomy

Comparison of Intraoperative Intravenous Lidocaine Infusion and Transversus Abdominis Plane (TAP) Block for Post-operative Analgesia Following Laproscopic Cholecystectomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05231941
Enrollment
90
Registered
2022-02-09
Start date
2022-02-25
Completion date
2022-10-17
Last updated
2024-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Operative Pain

Brief summary

This study is aimed to determine the post operative pain after laparoscopic cholecystectomy by dividing patients into three different group. Group A will receive lidocaine 2mg/kg bolus at induction followed by 1.5mg/kg/hr infusion. Group B will receive bilateral subcostal TAP block with 0.375% 20ml Ropivicaine on each side. Group C will not receive any additional pain regime apart from the routine intraoperative analgesics. Pain score will be assessed post operatively for 24 hours at regular intervals using visual analog score.

Interventions

DRUGLidocaine IV

Bolus and infusion of lidocaine will be administered

DRUGRopivacaine

Bilateral TAP block will be given to these patients

Sponsors

Aga Khan University Hospital, Pakistan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Age group (18-65) * Undergoing elective Laproscopic Cholecystectomy * ASA status I or II

Exclusion criteria

* Participation in any other trial * Known hypersensitivity to study medications * Chronic Opioid used * Seizure disorder

Design outcomes

Primary

MeasureTime frameDescription
Pain scoreOn arrival in PACU (0 hours)Pain score will be assessed using visual analog scoring system (0: No pain and 10: Worst Imaginable Pain)
Pain ScoreAt 24 hoursPain score will be assessed using visual analog scoring system (0: No pain and 10: Worst Imaginable Pain)

Secondary

MeasureTime frameDescription
Post operative nausea and vomitingOn arrival, At 2 hours, 4 hours, 6 hours, 12 hours and 24 hoursNausea and vomiting score would be assess using Bellville scoring system (0: No nausea or vomiting, 1: nausea, 2: nausea and belching, 3: vomiting)
Patient SatisfactionAt 24 hours or dischargePatient satisfaction will be assessed on Likert Scale (Completely Disagree, Disagree, Neutral, Agree, Completely Agree)

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026